Status:
COMPLETED
Home Monitoring and Evaluation After Admission for COVID-19 in the Netherlands
Lead Sponsor:
Erasmus Medical Center
Collaborating Sponsors:
Leiden University Medical Center
Amsterdam UMC, location VUmc
Conditions:
COVID-19
Pulmonary Fibrosis
Eligibility:
All Genders
18+ years
Brief Summary
To date, little is known about the short and long-term complications of COVID-19. In order to obtain more insights in disease course and recovery of COVID-19 and to improve care after hospital admissi...
Detailed Description
Patients with COVID-19 have a variable disease course and recovery. After the SARS coronavirus outbreak in 2003, many patients developed pulmonary fibrosis. Emerging data from the COVID-19 outbreak su...
Eligibility Criteria
Inclusion
- Patients admitted to the hospital with proven COVID-19 infection
- Abnormalities on Chest X-ray/HRCT due to COVID-19 infection
Exclusion
- Not able to speak, read or write in the native language of the country where the patient is included
- Not able to comply to the study protocol, according to the judgement of the investigator and/or patient
- No access to internet
Key Trial Info
Start Date :
March 19 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 26 2022
Estimated Enrollment :
133 Patients enrolled
Trial Details
Trial ID
NCT04488562
Start Date
March 19 2020
End Date
February 26 2022
Last Update
February 15 2023
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Amsterdam University Center - location VUmc
Amsterdam, Netherlands, 1081 HV
2
Leiden University Medical Center
Leiden, Netherlands, 2333 ZA
3
Erasmus MC
Rotterdam, Netherlands, 3015 CD